Menu
Your Cart

Financing Your Purchase

 

Financing Your Purchase through Apostle Capital

Apostle Capital offers an optional financing opportunity for purchase amount greater than $25,000. For details about this program, send an inquiry to:
Email: support@apostlebio.com.
Tel: 1-888-305-3218
Apostle Capital is in collaboration with Mitsubishi HC Capital America.

Apostle Capital Partners

Nature Communications just published a clinical study, including 2125 cancer patients, 9 cancer types, using the Apostle Minimax cfDNA technology. This study demonstrates the ability of its model to detect early-stage cancers using cfDNA, including those of pancreatic origin, with high sensitivity that is comparable to that of late-stage detection. Congratulations to this clinical research team. To date, the Apostle Minimax cfDNA technology has been used in 2 articles published in Nature Medicine, 1 in Nature Communications, 1 in Science Translational Medicine, 1 in PNAS, and over 50 scientific articles in different journals.